Chemical Profiles and Anti-inflammatory Activity of the Essential Oils from Seseli gummiferum and Seseli corymbosum subsp. corymbosum

Nat Prod Commun. 2016 Oct;11(10):1523-1526.

Abstract

The anti-inflammatory activity of the essential oils from Seseli corymbosum subsp. coiymbosum Pall. ex Sm. (SC) and Seseli gummiferum Boiss. & Heldr. subsp. corymbosum (SG) was investigated for the first time on lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. The main constituents (determined by GC-FID and GC-MS analyses) were germacrene D (54.1%) and sabinene (22.4%) in SG oil and β-phellandrene (29.2%), α-phellandrene (8.2%) and germacrene D (2.5%) in SC oil. SC and SG oils inhibited nitric oxide (NO) production with IC50 values of 56.1 and 108.2 μg/mL, respectively. The oils also inhibited prostaglandin E2 (PGE2) with IC50 values of 49.4 μg/mL (SC oil) and 95.5 μg/mL (SG oil). The inhibitory effect of SC and SG oils was accompanied by dose-dependent decreases of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expressions in LPS-induced RAW 264.7 cells. The research of the reporter gene assay on nuclear factor KB (NF-KB) showed that SC and SG oils inhibited NF-KB transcriptional activity. The obtained results suggest that SC and SG oils exert the anti-inflammatory effects in LPS-stimulated RAW 264.7 cells by suppressing NF-KB activation.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Apiaceae / chemistry*
  • Cell Survival / drug effects
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Dinoprostone / antagonists & inhibitors
  • Enzyme Inhibitors / pharmacology
  • Gas Chromatography-Mass Spectrometry
  • Genes, Reporter / drug effects
  • Lipopolysaccharides / pharmacology
  • Mice
  • NF-kappa B / drug effects
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Oils, Volatile / chemistry
  • Oils, Volatile / pharmacology*
  • RAW 264.7 Cells

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • NF-kappa B
  • Oils, Volatile
  • Nitric Oxide Synthase Type II
  • Dinoprostone